Saturday 17 October 2026
Export CV’s income statement to Excel — free account
CapsoVision, Inc.
CapsoVision, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 million, up 15.3% from fiscal 2024. In the quarter to June 2026, revenue grew 9.89%, EPS grew 92.6% and free cash flow fell 84.4%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
6.53
0.08
+1.24%
Follow CV
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+5 more quarters Free account |
0.00 | 0.00 | 5.57 | 2.38 |
P/S ratio |
17.75 | 19.37 | 25.51 | 27.25 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(39.48) | (34.15) | (57.03) | (45.05) | |
P/B ratio |
10.94 | 19.80 | 17.11 | 28.75 | |
Price to Tangible BV |
10.94 | 19.80 | 17.11 | 28.75 | |
EV/Sales |
16.34 | 18.62 | 24.19 | 26.60 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(10.01) | (11.04) | (13.70) | (13.28) | |
EV/FCF |
(9.97) | (11.00) | (13.64) | (13.25) | |
Quick Ratio |
4.24 | 2.85 | 3.70 | 2.20 | |
Current Ratio |
5.19 | 3.77 | 4.57 | 3.35 | |
Net Debt/EBITDA |
2.26 | 1.38 | 2.58 | 1.22 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.98 | 1.49 | 1.05 | 0.99 | |
Operating CF/Net income |
0.72 | 1.04 | 0.86 | 1.12 | |
Capex/Depreciation |
(0.08) | (0.05) | (0.32) | 0.00 | |
Research and Development Expense of Revenue |
172.13% | 146.02% | 158.85% | 145.73% | |
Selling, General and Administrative Expense of Revenue |
108.62% | 94.36% | 142.80% | 113.70% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
8.68% | 5.03% | 11.96% | 15.84% | |
Graham Net Nets |
0.08 | 0.04 | 0.05 | 0.03 | |
Graham Number |
0.00 | 0.00 | 3.54 | 4.34 | |
Earnings Yield |
(154.35%) | (9.65%) | 17.96% | 41.94% | |
Free Cash Flow Yield |
(9.24%) | (8.74%) | (6.95%) | (7.37%) | |
Revenue per Share |
0.08 | 0.16 | 0.06 | 0.07 | |
Operating CF per Share |
(0.12) | (0.31) | (0.13) | (0.17) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.12) | (0.31) | (0.13) | (0.17) | |
Cash per Share |
0.38 | 0.41 | 0.38 | 0.18 | |
Shareholders Equity per Share |
0.44 | 0.54 | 0.43 | 0.26 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.44 | 0.54 | 0.43 | 0.26 | |
Free Cash Flow |
(5.68) | (7.69) | (6.11) | (8.40) | |
Working Capital |
19.41 | 12.24 | 19.14 | 12.12 | |
Capital Expenditures |
(0.01) | (0.01) | (0.05) | 0.00 | |
Net Current Asset Value |
18.83 | 11.77 | 18.78 | 11.88 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.02 | 0.00 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
— | — | 1.96 | 2.06 | |
Average Payables |
— | — | 1.05 | 0.82 | |
Average Inventory |
— | — | 3.06 | 3.87 | |
Average Assets |
12.83 | 9.08 | 12.97 | 14.06 | |
Average Common Equity |
— | — | (54.64) | (62.91) |
Columns are period end dates